← Back to Search

Somatosensory Rehabilitation Program for Vulvodynia

N/A
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in the scores from pre- to 2-week post-treatment, from 2-week post-treatment to 3-month post-treatment, and from pre-treatment to 3-month post-treatment
Awards & highlights

Summary

This trial is testing two programs to help women with chronic vulva pain. One program uses gentle touch near the painful area to reduce sensitivity, while the other teaches about hygiene, pain, and relaxation. The goal is to see if these programs are practical and helpful for these women.

Eligible Conditions
  • Vulvodynia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in the surface from pre- to 2-week post-treatment, from 2-week post-treatment to 3-month post-treatment, and from pre-treatment to 3-month post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in the surface from pre- to 2-week post-treatment, from 2-week post-treatment to 3-month post-treatment, and from pre-treatment to 3-month post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence rate to assessment sessions
Adherence rate to home exercises
Patients' adherence rate to treatment sessions
+3 more
Secondary study objectives
12-item Short Form Survey (SF-12 v2)
Adverse events
Beck Depression Inventory questionnaire (BDI-II)
+16 more
Other study objectives
Short-Leeds Assessment for Neuropathic Symptoms and Signs (S-LANSS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Somatosensory Rehabilitation ProgramExperimental Treatment1 Intervention
Includes minimizing contact with the painful zone of the vulva and uses tactile stimulation at a tolerated distance from the vulva. Each participant will also receive advice on resuming sexual activities with vaginal penetration.
Group II: Educational Pain Management Program (PMP)Active Control1 Intervention
Includes education on decreasing irritative contacts with the vulva and relaxation techniques. Each participant will also receive advice on resuming sexual activities with vaginal penetration.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,373 Previous Clinical Trials
26,519,197 Total Patients Enrolled
1 Trials studying Vulvodynia
212 Patients Enrolled for Vulvodynia
Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER
61 Previous Clinical Trials
33,469 Total Patients Enrolled
3 Trials studying Vulvodynia
223 Patients Enrolled for Vulvodynia
Université de SherbrookeLead Sponsor
302 Previous Clinical Trials
70,218 Total Patients Enrolled
6 Trials studying Vulvodynia
553 Patients Enrolled for Vulvodynia
~14 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top